Application 219227
- Type
- ANDA
- Sponsor
- APOTEX
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NINTEDANIB ESYLATE | NINTEDANIB ESYLATE | CAPSULE;ORAL | EQ 100MG BASE | No | No |
| 002 | NINTEDANIB ESYLATE | NINTEDANIB ESYLATE | CAPSULE;ORAL | EQ 150MG BASE | No | No |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 85638 | ORIG | 2026-04-06 |